未登录

J

Joseph P. Schacht

university of colorado anschutz medical school

H指数:26

被引数:2,891

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cannabidiol and Alcohol Use Disorders: An Updated Review of Therapeutic Potential

大麻二酚与酒精使用障碍：治疗潜力的最新综述

Alcohol-Clinical and Experimental Research

IF2.7

2026-10-010

PRE

Examining the Impact of Trial Length on Detecting Medication Effects for Alcohol Use Disorder: A Meta-Regression Study

考察试验持续时间对检测酒精使用障碍药物效果的影响：一项Meta回归研究

alcohol, clinical and experimental research

IF0

2026-06-120

OA

Electrophysiology and functional MRI of cue craving: potential biomarkers for therapeutic neuromodulation in addiction

电生理学和功能磁共振成像在提示线索诱发渴求中的作用：成瘾治疗中神经调控的潜在生物标志物

Biological Psychiatry Global Open Science

IF0

2025-09-300

OAAI

The alcohol cue-exposure paradigm as a screening tool for alcohol use disorder medication development: A critical review

酒精线索暴露范式作为酒精使用障碍药物治疗开发的筛查工具：一项批判性综述

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

IF2.7

2025-09-010

OAAI

Brain glutathione levels and associations with recent drinking in treatment-naïve individuals with alcohol use disorder versus light drinkers

酒精使用障碍治疗-naïve个体的脑内谷胱甘肽水平及其与近期饮酒的关联性，与轻度饮酒者的比较

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-07-010

PRE

Effects of COMT suppression in a randomized trial on the neural correlates of inhibitory processing among people with Alcohol Use Disorder

COMT抑制在随机试验中对酒精使用障碍人群抑制性加工的神经相关物的影响

biological psychiatry cognitive neuroscience and neuroimaging

IF0

2025-06-130

PRE

Effects of a novel GABA-B positive allosteric modulator, ASP8062, on alcohol cue-elicited craving and naturalistic alcohol consumption in a multisite randomized, double-blind, placebo-controlled trial

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

IF2.7

2024-12-020

OA

Alcohol and brain structure across the lifespan: A systematic review of large-scale neuroimaging studies

ADDICTION BIOLOGY

IF2.6

2024-09-241

OA

Stress, Cues, and Craving: Does the Insula Hold the Key to Understanding Stress-Induced Drinking in Alcohol Use Disorder?

BIOLOGICAL PSYCHIATRY

IF9

2024-02-010

PRE

GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders

GLP-1受体激动剂是有希望但未经证实的酒精和物质使用障碍的治疗方法

NATURE MEDICINE

IF50

2023-11-2415

PRE

A randomized trial of the effects of COMT inhibition on subjective response to alcohol: Moderation by baseline COMT activity and mediation of alcohol self-administration

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

IF2.7

2023-11-210

PRE

Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone

NEUROPSYCHOPHARMACOLOGY

IF7.1

2022-05-069

OAAI

A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus

NATURE PROTOCOLS

IF16

2022-02-0430

OA

Ekhtiari, Hamed; Zare-Bidoky, Mehran; Sangchooli, Arshiya; Janes, Amy C.; Kaufman, Marc J.; Oliver, Jason A.; Prisciandaro, James J.; Wustenberg, Torsten; Anton, Raymond F.; Bach, Patrick; Baldacchino, Alex; Beck, Anne; Bjork, James M.; Brewer, Judson; Childress, Anna Rose; Claus, Eric D.; Courtney, Kelly E.; Ebrahimi, Mohsen; Filbey, Francesca M.; Ghahremani, Dara G.; Azbari, Peyman Ghobadi; Goldstein, Rita Z.; Goudriaan, Anna E.; Grodin, Erica N.; Hamilton, J. Paul; Hanlon, Colleen A.; Hassani-Abharian, Peyman; Heinz, Andreas; Joseph, Jane E.; Kiefer, Falk; Zonoozi, Arash Khojasteh; Kober, Hedy; Kuplicki, Rayus; Li, Qiang; London, Edythe D.; McClernon, Joseph; Noori, Hamid R.; Owens, Max M.; Paulus, Martin; Perini, Irene; Potenza, Marc; Potvin, Stephane; Ray, Lara; Schacht, Joseph P.; Seo, Dongju; Sinha, Rajita; Smolka, Michael N.; Spanagel, Rainer; Steele, Vaughn R.; Stein, Elliot A.; Steins-Loeber, Sabine; Tapert, Susan F.; Verdejo-Garcia, Antonio; Vollstaedt-Klein, Sabine; Wetherill, Reagan R.; Wilson, Stephen J.; Witkiewitz, Katie; Yuan, Kai; Zhang, Xiaochu; Zilverstand, Anna

Clinical and Neural Correlates of Reward and Relief Drinking

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

IF2.7

2020-11-1720

OAAI

Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

IF2.7

2020-09-193

OAAI

Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder

IF5.3

2020-02-1123

OAAI

Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder

ADDICTION BIOLOGY

IF2.6

2019-08-0120

OAAI

Preliminary evidence that computerized approach avoidance training is not associated with changes in fMRI cannabis cue reactivity in non-treatment-seeking adolescent cannabis users

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2019-07-0116

OAAI

Investigating a novel fMRI cannabis cue reactivity task in youth

ADDICTIVE BEHAVIORS

IF3.6

2019-02-0135

OAAI

The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms

ADDICTION BIOLOGY

IF2.6

2018-09-184

PREAI